News and Events

KGM Get Certificate of ISO 14001:2015 & 45001:2018


After passing steps of audit, PT Kalbio Global Medika (KGM) get international certificate of ISO 14001:2015 (Environmental Management System) and ISO 45001:2018 (Occupational Health and Safety Management System). The certificate is issued by Business Systems Certification accredited by JAS-ANZ (Joint Accreditation System of Australia & New Zealand). This achievement shows that KGM has comply to international requirement in occupational health safety and environment management system also to increase the opportunity of business development. Congrats KGM!


KGM at a Glance

Kalbio Global Medika (KGM) is one of the first and the pioneer of biopharmaceuticals in Indonesia, established in 2014 and inaugurated officially in 2018 by the President of the Republic of Indonesia, Ir. Joko Widodo. KGM is part of the Kalbe Group, a subsidiary of PT Kalbe Genexine Biologics (KGbio), which is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside US/Canada, Western Europe, and China. KGM is an Innovative CDMO, equipped with CMC and scale-up capabilities plugged into Boston biotech ecosystem and state-of-the-art facility to enhance efficiency and productivity. With API manufacturing, formulation, fill and finish capabilities of biosimilar and novel biologics, averaging 10 million units of syringes, cartridges, and vials, KGM supplies local and international markets.